University of Illinois Chicago
Chicago, Illinois, 60612, United States
NCT Number: NCT06675799
The goal of this interventional study is to learn if a digital sleep extension intervention can improve sleep and mood in young urban adults with mood symptoms. The main questions it aims to answer are:
Will this intervention improve sleep? Will this intervention improve mood? Does the effect of this intervention change based on environmental factors like noise and light pollution?
Researchers will compare participants receiving the sleep intervention to participants receiving a "general healthy living" intervention to see if outcome are different across groups.
Participants will:
* receive 6 weeks of brief once weekly telephone coaching and read once weekly educational content * have their sleep monitored daily with a FitBit and Somnofy sleep device and during the 6-week intervention period * respond to questionnaires at the start of the intervention, halfway through the intervention, at the end of the intervention, and finally 4 weeks after completing the intervention
Looking for future studies?
Notify Me18 year–30 year
All sexes
Interventional
Not applicable
Chicago, Illinois, 60612, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Weekly educational material about sleep health and weekly brief phone coaching calls for a total of 6 weeks.
Weekly educational materials about healthy habits and weekly brief phone calls to clarify terms or concepts.
Time frame: From enrollment to the end of post-treatment follow-up period (10 weeks after start of intervention)
Measured by the number of participants approached, recruited and retained
Time frame: From enrollment to the end of post-treatment follow-up period (10 weeks after start of intervention)
Measured by sessions completed
Time frame: At end of 6-week intervention
Acceptability of Intervention Measure
Time frame: From enrollment to the end of post-treatment follow-up period (10 weeks after start of intervention)
Measured by Fitbit
Time frame: From enrollment to the end of post-treatment follow-up period (10 weeks after start of intervention)
Measured by Fitbit
Time frame: From enrollment to the end of post-treatment follow-up period (10 weeks after start of intervention)
Measured by Fitbit
Time frame: From enrollment to the end of post-treatment follow-up period (10 weeks after start of intervention)
Measured with the Pittsburgh Sleep Quality Index (PSQI), where higher scores indicate poorer sleep quality.
Time frame: From enrollment to the end of post-treatment follow-up period (10 weeks after start of intervention)
Anxiety, depression, and stress as measured with the Depression, Anxiety and Stress Scale - 21 item (DASS-21), where higher scores mean more distress.
Time frame: From enrollment to the end of post-treatment follow-up period (10 weeks after start of intervention)
PROMS-Fatigue 8 item
Time frame: From enrollment to the end of post-treatment follow-up period (10 weeks after start of intervention)
Bedtime Procrastination Scale where higher scores equal more procrastination.
Time frame: Pre-treatment and at 6-week post-treatment assessment
2 items taken from National Sleep Foundation 2011 Sleep in America survey
University of Illinois at Chicago
Other
Sleep Extension to Improve Mood in Young Urban Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07566273
Chemically-Induced Disorders, Internalizing Mental Health Symptoms
New York, United States
View Trial DetailsNCT05846282
Allostatic Load, Health Complaints
Los Angeles, California, United States
View Trial DetailsNCT06638853
Distress, Emotional, Internalizing Mental Health Symptoms
Beaverton, Oregon, United States
View Trial DetailsNCT07659171
Anxiety Disorders, Behavior
Reykjavik, Iceland
View Trial Details